Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Ries

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Oncogene|February 15, 2012
CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironmentY Sambandam, K Sundaram, A Liu, et al.
Bone|January 1, 1990
Oxygen derived free radicals in osteoclasts: the specificity and location of the nitroblue tetrazolium reactionL L Key, W L Ries, R G Taylor, et al.
The Journal of Pathology|October 18, 2007
Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotypeS Shanmugarajan, K Irie, C Musselwhite, et al.
The New England Journal of Medicine|June 15, 1995
Long-term treatment of osteopetrosis with recombinant human interferon gammaL L Key, R M Rodriguiz, S M Willi, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Oncogene|February 15, 2012
CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironmentY Sambandam, K Sundaram, A Liu, et al.
Bone|January 1, 1990
Oxygen derived free radicals in osteoclasts: the specificity and location of the nitroblue tetrazolium reactionL L Key, W L Ries, R G Taylor, et al.
The Journal of Pathology|October 18, 2007
Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotypeS Shanmugarajan, K Irie, C Musselwhite, et al.
The New England Journal of Medicine|June 15, 1995
Long-term treatment of osteopetrosis with recombinant human interferon gammaL L Key, R M Rodriguiz, S M Willi, et al.
Pageof 3